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• CAPCaT Fast-Track Program for SARS-CoV-2 Test Development 
• UMMS Update 
• NIH Update 
• COVID-19 Clinical Trials Database 
• The National COVID Cohort Collaborative (N3C) 
 
EVENTS 
• MALSI+ 2020 
• Panel Discussion- Demystifying Pathways to Innovation Partnerships with Health Systems 
• 2020 M2D2 $200K Challenge Pitch-Off and Award Celebration 
 
FUNDING 
• CCTS SPARK Program (Small Pilot and Research Knowledge) 
• CTS Small Conference Grants 
• PRACCTIS program postdoctoral fellowship 
• Multimorbidity Funding Opportunity Announcements, Technical Assistance Webinar  
• NIH Funding Opportunity: Automatic detection and tracing of SARS-CoV-2 (U01)  
 
EDUCATION 
• Greater Worcester Covid-19 Survey 
• Patient-Facing Survey: What’s Your Take on New Medical Technology? 
• Two free Community Health Maps webinars this month 
  
DID YOU KNOW 
• HRPP QA/QI 
• National Center for Data to Health (CD2H)   
 
COVID-19 
UMASS CAPCaT TEAM LEADING EFFORT FOR COVID-19 TEST DEVELOPMENT AND 
DISTRIBUTION: The NIH is urgently soliciting proposals and can provide up to $500M 
across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will 
assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx) 
is a fast-track technology development program that will support novel solutions that build the 
U.S. capacity for testing up to 100-fold above what is achievable with standard approaches. 
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RADx is structured to deliver innovative testing strategies to the public as soon as late 
summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make 
SARS-CoV-2 testing readily available to every American. 
 
The application portal is now live www.poctrn.org/radx . 
For more information: https://www.youtube.com/watch?v=ofAldSGoZOg 
 
UMMS UPDATE regarding human subjects research during the COVID-19 pandemic can be 
found here: https://umassmed.edu/ccts/covid-19/. This website is updated frequently. 
 
NIH UPDATE: For up-to-date NIH COVID-19 information, including informational videos, 
proposal submission and award management resources, human subjects and clinical trials 
guidance, animal welfare, frequently asked questions regarding flexibilities for grantees, and 
funding opportunities, click here: https://www.nih.gov/health-information/coronavirus  
 
CLINICAL TRIALS DATABASE: To search for active Covid-19 clinical trials at UMMS, 
please visit https://www.conqueringdiseases.org/ . Conquering Diseases is an easy to use 
web-based search tool to find, share and save clinical studies relevant to patients. It also 
provides educational resources to help patients and families learn about and find clinical 
studies. It provides a patient-friendly and direct way to learn about clinical studies and a 
secure environment to share clinical study opportunities and communicate with study staff for 
screening and enrollment into clinical studies. 
 
THE NATIONAL COVID COHORT COLLABORATIVE (N3C): The National Center for Data 
to Health (CD2H) and NCATS are creating a centralized, secure portal for hosting row-level 
COVID-19 clinical data – the National COVID Cohort Collaborative (N3C). This initiative is a 
partnership between the CTSA program, several HHS agencies, and the distributed clinical 
data networks PCORnet, OHDSI, ACT/i2b2, and TriNetX. We believe the N3C portal will 
enable the rapid development of analytics that clinical centers and physicians need now.  To 
learn more, visit https://covid.cd2h.org/N3C 
 
EVENTS 
MALSI+ 2020: August 20, 2020, 10AM-3PM: Don’t miss a great opportunity to learn from, 
and connect with, scientific innovators, entrepreneurs, business leaders, and investors whose 
groundbreaking work across the globe is addressing Life Science innovation. Expand your 
understanding and international network by joining thought-provoking conversations on a 
variety of timely topics. The virtual format features curated small group and 1:1 networking, 
as well as a limited number of keynote and panel presentations. For more information and to 
register visit: https://mttc.org/malsi-2020/  
 
Panel Discussion- Demystifying Pathways to Innovation Partnerships with Health 
Systems, Tuesday, August 25 • 10am-Noon ET: How do you get hospital systems to try, 
adopt, and embrace your product? That's the million-dollar question for life sciences 
innovators, and you'll get answers from hospital stakeholders and decision-makers in this free 
forum. UMass is honored to partner with BARDA, the VA, and Texas Medical Center's 
2
UMass Center for Clinical and Translational Science Newsletter, Vol. 2020 [2020], Iss. 8, Art. 1
https://escholarship.umassmed.edu/umccts_news/vol2020/iss8/1
DOI: 10.13028/4hzd-7m10
renowned and influential Innovation Institute for this event, which is OPEN TO ALL innovators 
seeking that elusive "foot in the door." 
For more details and to register visit: https://www.eventbrite.com/e/demystifying-pathways-to-
innovation-partnerships-with-health-systems-tickets-111833376640?aff=M2D2 
 
2020 M2D2 $200K Challenge Pitch-Off and Award Celebration: M2D2 is thrilled to 
announce that we have officially rescheduled the 2020 M2D2 $200K Challenge Pitch-Off and 
Award Celebration—now virtual and free of charge. Mark your calendars:  
 
Finalist Pitch-Off: Thursday, September 17 at 5pm ET 
Awards Celebration: Thursday, October 1 at 5 pm ET 
 




CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to 
support studies that impact clinical care and research methodologies, support 
students/trainees, and provide access to funds to generate pilot and preliminary data for 
external grant submissions.  For more information, click on this link: 
https://www.umassmed.edu/ccts/funding/spark-program/ 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding 
facilitates the development of faculty-to-faculty networks within the University system.  Click 
on this link for more information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
FUNDING OPPORTUNITY: postdoctoral fellowships to prepare the next generation of 
scientists to conduct implementation research that addresses critical cancer prevention and 
control care delivery issues. 
PRACCTIS program postdoctoral fellowship: Funding opportunity!  Deadline extended for 
postdoctoral fellows. The National Cancer Institute-funded T32 PRACCTIS program 
(Prevention and Control of Cancer: Training for Change in Individuals and Systems) is now 
accepting applications for postdoctoral trainees to start August 2020 or later. PRACCTIS is 
an NCI-funded training program designed to prepare the next generation of scientists to 
conduct implementation research that addresses critical cancer prevention and control care 
delivery issues across the cancer continuum, including primary prevention, cancer screening, 
diagnosis, treatment and survivorship.  
• Trainees must be interested in pursuing a career focused on cancer prevention and 
control implementation research. All applicants must pursue independent research in 
this area.  
• Eligible trainees will have with doctoral degrees (MD, DO, Ph.D., Sc.D., etc.) and a 
primary mentor affiliated with one of the partnering institutions. External candidates will 
be matched with a mentor during the interview process. 
• Full applications are due by August 31, 2020. 
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For more information, contact barbara.estabrook@umassmed.edu  and see 
www.umassmed.edu/pracctis  
  
Multimorbidity Funding Opportunity Announcements Technical Assistance Webinar, 
Tuesday, September 1, 12:30-2:00PM EDT: This pre-application technical assistance 
webinar will provide an overview of the two NIH multimorbidity funding opportunity 
announcements (FOAs) listed below. These FOAs are soliciting innovative research to better 
understand, measure, and intervene on multimorbidity, or multiple chronic conditions.  
• PAR-20-179: Advancing Research To Develop Improved Measures and Methods for 
Understanding Multimorbidity (R01 Clinical Trial Optional)  
• PAR-20-180: Identifying Innovative Mechanisms or Interventions That Target 
Multimorbidity and Its Consequences (R01 Clinical Trial Optional) 
NIH Funding Opportunity: Automatic detection and tracing of SARS-CoV-2 (U01): This 
RFA will support the early stage development of innovative platforms that integrate 
biosensing with touchscreen or other digital devices to achieve detection & tracing of SARS-
CoV-2 in real-time; deadline September 15, 2020 




GREATER WORCESTER COVID-19 COMMUNITY HEALTH SURVEY: UMass Medical 
School, in collaboration with the City of Worcester and the Central Massachusetts Regional 
Public Health Alliance is conducting the Great Worcester COVID-19 Community Health 
Survey.  The online survey, which takes about 10 minutes to complete, asks respondents 
about changes in their lives due to COVID since March 10, including their health, finances, 
activities outside the home, access to medical care, employment, housing and food security. 
The names of the street a respondent lives on and the closest cross street will be vital for 
understanding circumstances in specific neighborhoods. Providing contact information is 
optional for respondents who want to receive survey results, and who are willing to be 
contacted about the survey. The survey also provides a list of local resources for households 
experiencing distress due to COVID-19. The survey is available in English, Spanish, 
Portuguese, Vietnamese, Albanian and Russian. To participate, please click here. 
UMASS PATIENT SURVEY: WHAT’S YOUR TAKE ON THE USE OF TECHNOLOGY IN 
HEALTH CARE? We want your advice on which new medical technologies should be 
developed to help you and your healthcare provider. We value your opinion about which 
medical tests you believe would be most helpful. Your input is invaluable for guiding support 
toward products that will do the most good.  
 
Researchers at the University of Massachusetts focused on heart, lung, blood, and sleep 
disorders (CAPCaT) have created a brief survey that will help inform how we support 
promising new technologies. This survey has 21 questions and should take about 10 minutes 
to complete. Participation is entirely voluntary, and you can stop at any time. Your survey 
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responses will be anonymous. Thank you in advance for providing critical feedback to 
CAPCaT. 
 
To participate click here: https://arcsapps.umassmed.edu/redcap/surveys/?s=AK3ET3RTLY 
 
If you have any questions, please contact Nate Hafer at nathaniel.hafer@umassmed.edu. 
 
Two free Community Health Maps webinars this month: Community Health Maps works 
to enable community health advocates to meet local health mapping needs through training 
on low cost resources for spatial data collection, mapping, and sharing.  
The first webinar (August 14, 2:00-3:00pm EDT) will provide an introduction to mapping 
COVID-19 data using the free and open source QGIS desktop software. (Details and 
registration here) 
  
The second webinar (August 21, 2:00-3:00pm EDT) will introduce a new workflow for mobile 
data collection using the app Input. (Details and registration here) 
  
No prior experience using QGIS or other GIS software is required. Both webinars will be 
recorded. If you are not able to attend the live events, please register to receive notification 
about the recordings. 
  
Feel free to contact Marisa Conte (meese@umich.edu) or Tyler Nix (tnix@umich.edu) with 
any questions.   
 
DID YOU KNOW? 
 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and 
Translational Science. The program is independent of the IRB and helps study teams and 
investigators by conducting routine post-approval monitoring of on-going research to evaluate 
adherence with institutional requirements and federal regulations. If there are review findings, 
the QA/QI manager shares those findings with investigators and study teams, and provides 
direct education on the findings, including how to avoid making similar errors in the future. In 
order to support improvement at an institutional level, the QA/QI manager shares aggregated 
data from reviews with the HRPP leadership and the Research Community to identify trends 
and target areas for education. The program also makes self-evaluation tools available to 
investigators and study teams seeking to perform their own assessments.  To learn more 
about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data 
more meaningful, open and accessible. The CD2H supports a vibrant and evolving 
collaborative informative ecosystem for the CTSA program and beyond. The CD2H 
harnesses and expands an ecosystem for translational scientists to discover and share their 
software, data and other research resources within the CTSA program network.  The CD2H 
also creates a social coding environment for translational science institutions, leveraging the 
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community-driven DREAM challenges as a mechanism to stimulate innovation. To learn 
more, click here. 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and 
Translational Science?  Has your patent been filed on technology developed using Center 
funding or resources? Did your pilot project receive external grant funding? Share it with us at 
ccts@umassmed.edu. Sharing your success demonstrates the importance and effect of the 
Center for Clinical and Translational Science at UMass. 
 
 
CITE & SUBMIT 
Please cite the NIH CTSA award any time you use The UMMS Center for Clinical and 
Translational Science resources, services and facilities or received funding through the 
Center. “The project described is supported by the National Center for Advancing 
Translational Sciences, National Institutes of Health, through Grant UL1 TR001453, (or 
TL1 TR001454, or KL2 TR001455, as appropriate). The content is solely the 
responsibility of the authors and does not necessarily represent the official views of 
the NIH.”  
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send 
announcements, including a link, to ccts@umassmed.edu. The newsletter is published the 
first week of each month. 
 
University of Massachusetts Center for Clinical and Translational Science, 55 Lake Avenue N, Worcester MA 
01655 
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